Archive · 8 Dec 2025
Acne Drug Shows Promise in Treating Male Baldness
Scientists have found that a drug used to treat acne might also help with male pattern baldness.
This type of hair loss affects many men in their late 20s and early 30s.
The drug, called clascoterone, was tested in two big studies with over 1,500 men.
In one study, it helped hair grow back 539% more, and in another, it helped 168% more.
The company that made the drug says it is safe to use.
If the drug gets approved by the FDA next year, it could be the first new treatment for male pattern baldness in 30 years.
This is good news for many people who have been trying to find a way to stop or reverse their hair loss.
Clascoterone, an acne drug, shows significant promise in treating male pattern baldness.
Two phase III trials showed improvements of 539% and 168% in hair restoration.
The drug is considered safe and tolerable with minimal side effects.
FDA approval is expected next year, making it the first new treatment in 30 years.
The drug was previously approved for acne treatment in 2020.
- Who
- Men in their late 20s and early 30s
- What
- Clascoterone, an acne drug, shows promise in treating male pattern baldness
- When
- Results announced on November 31, 2025
- Where
- Trials conducted by Cosmo Pharmaceuticals, based in Ireland
- Why
- To address male pattern baldness, a common type of hair loss
- Drug Name
- Clascoterone
- Company
- Cosmo Pharmaceuticals
- Trial Improvement
- 539% and 168% in two trials
- Side Effects
- Safe and tolerable
- FDA Approval
- Expected next year
- Previous Use
- Acne medication since 2020
- Target Group
- Men in late 20s and early 30s